MARKET

CLDX

CLDX

Celldex Therapeutics Inc
NASDAQ
23.87
-0.74
-2.99%
Opening 11:24 02/12 EST
OPEN
24.57
PREV CLOSE
24.60
HIGH
24.78
LOW
23.52
VOLUME
45.44K
TURNOVER
--
52 WEEK HIGH
30.50
52 WEEK LOW
14.40
MARKET CAP
1.59B
P/E (TTM)
-7.0569
1D
5D
1M
3M
1Y
5Y
1D
Celldex Therapeutics to Present at Major Investor Conferences
Reuters · 3d ago
Weekly Report: what happened at CLDX last week (0202-0206)?
Weekly Report · 3d ago
Celldex to Present at Upcoming Investor Conferences
Barchart · 3d ago
Celldex Therapeutics Breaks Below 200-Day Moving Average - Notable for CLDX
NASDAQ · 6d ago
Weekly Report: what happened at CLDX last week (0126-0130)?
Weekly Report · 02/02 09:52
Celldex’s EvolvE Study Completion Sets Up Key Catalyst in Eosinophilic Esophagitis
TipRanks · 01/30 16:30
2 ‘Strong Buy’ Growth Stocks With Upside of Around 200%
Barchart · 01/27 15:02
Weekly Report: what happened at CLDX last week (0119-0123)?
Weekly Report · 01/26 09:53
More
About CLDX
Celldex Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on exploring the science of mast cell biology and the development of transformative therapeutics for patients. Its pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Its drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases. Its Barzolvolimab (CDX-0159) is a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is being studied across multiple mast cell driven diseases, including Chronic Urticarias, Prurigo Nodularis, Atopic Dermatitis and Eosinophilic Esophagitis. The Company’s bispecific platform includes CDX- 622. The CDX- 622 is a bispecific candidate for inflammatory diseases.

Webull offers Celldex Therapeutics Inc stock information, including NASDAQ: CLDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLDX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLDX stock methods without spending real money on the virtual paper trading platform.